Kenneth C. Lamp

2.6k total citations
58 papers, 2.0k citations indexed

About

Kenneth C. Lamp is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Kenneth C. Lamp has authored 58 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Infectious Diseases, 24 papers in Epidemiology and 22 papers in Clinical Biochemistry. Recurrent topics in Kenneth C. Lamp's work include Antimicrobial Resistance in Staphylococcus (37 papers), Bacterial Identification and Susceptibility Testing (22 papers) and Antibiotics Pharmacokinetics and Efficacy (16 papers). Kenneth C. Lamp is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (37 papers), Bacterial Identification and Susceptibility Testing (22 papers) and Antibiotics Pharmacokinetics and Efficacy (16 papers). Kenneth C. Lamp collaborates with scholars based in United States, Switzerland and Japan. Kenneth C. Lamp's co-authors include Collin D. Freeman, Neil E. Klutman, Michael J. Rybak, Lawrence V. Friedrich, Melinda K. Lacy, E. Bailey, Glenn W. Kaatz, Pamela Moise, Donald P. Levine and Maria Amodio-Groton and has published in prestigious journals such as Blood, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

Kenneth C. Lamp

57 papers receiving 1.9k citations

Peers

Kenneth C. Lamp
Barry Hafkin United States
Jon Bruss United States
Wendy Munckhof Australia
A.P.R. Wilson United Kingdom
S. J. van Hal Australia
Silvano Esposito Italy
Donald H. Batts United States
Peter K. Linden United States
Kenneth J. Tack United States
James A. McKinnell United States
Barry Hafkin United States
Kenneth C. Lamp
Citations per year, relative to Kenneth C. Lamp Kenneth C. Lamp (= 1×) peers Barry Hafkin

Countries citing papers authored by Kenneth C. Lamp

Since Specialization
Citations

This map shows the geographic impact of Kenneth C. Lamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth C. Lamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth C. Lamp more than expected).

Fields of papers citing papers by Kenneth C. Lamp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth C. Lamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth C. Lamp. The network helps show where Kenneth C. Lamp may publish in the future.

Co-authorship network of co-authors of Kenneth C. Lamp

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth C. Lamp. A scholar is included among the top collaborators of Kenneth C. Lamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth C. Lamp. Kenneth C. Lamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frankenfeld, Celeste, et al.. (2018). Daptomycin: a comparison of two intravenous formulations. Drug Design Development and Therapy. Volume 12. 1953–1958. 7 indexed citations
2.
Hermsen, Elizabeth D., et al.. (2016). A retrospective study of outcomes of device-associated osteomyelitis treated with daptomycin. BMC Infectious Diseases. 16(1). 310–310. 7 indexed citations
3.
Moise, Pamela, Annie Wong‐Beringer, Kenneth C. Lamp, et al.. (2015). Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation. Clinical Therapeutics. 38(1). 16–30. 50 indexed citations
4.
Lamp, Kenneth C., et al.. (2015). Duration of prior vancomycin therapy and subsequent daptomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia. Diagnostic Microbiology and Infectious Disease. 83(2). 193–197. 2 indexed citations
5.
Joseph, Warren S., et al.. (2014). Daptomycin for Methicillin-Resistant Staphylococcus aureus Diabetic Foot Infections. Journal of the American Podiatric Medical Association. 104(2). 159–168. 4 indexed citations
6.
McDaneld, Patrick M., et al.. (2014). Outcomes and Metrics for Antimicrobial Stewardship: Survey of Physicians and Pharmacists. Clinical Infectious Diseases. 59(suppl_3). S108–S111. 19 indexed citations
7.
DePestel, Daryl D., Edward H. Eiland, Katherine Lusardi, et al.. (2014). Assessing Appropriateness of Antimicrobial Therapy: In the Eye of the Interpreter. Clinical Infectious Diseases. 59(suppl_3). S154–S161. 38 indexed citations
8.
Mueller, Bruce A., et al.. (2011). Safety of Daptomycin in Patients Receiving Hemodialysis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(7). 665–672. 13 indexed citations
9.
DePestel, Daryl D., Ellie Hershberger, Kenneth C. Lamp, & Preeti Malani. (2010). Safety and clinical outcomes among older adults receiving daptomycin therapy: Insights from a patient registry. ˜The œAmerican journal of geriatric pharmacotherapy. 8(6). 551–561. 4 indexed citations
10.
Owens, Robert C., et al.. (2007). Postmarketing Clinical Experience in Patients with Skin and Skin-Structure Infections Treated with Daptomycin. The American Journal of Medicine. 120(10). S6–S12. 30 indexed citations
11.
Sakoulas, George, et al.. (2007). Daptomycin in the Treatment of Bacteremia. The American Journal of Medicine. 120(10). S21–S27. 39 indexed citations
12.
Lamp, Kenneth C.. (2007). Experience with Daptomycin for Community-Associated Methicillin-Resistant Staphylococcus aureus Phenotype (CPMRSA) Osteomyelitis. 1 indexed citations
13.
Holtom, Paul, et al.. (2007). Clinical Experience with Daptomycin Treatment of Foot or Ankle Osteomyelitis. Clinical Orthopaedics and Related Research. 461. 35–39. 10 indexed citations
14.
Rolston, Kenneth V. I., John Segreti, Kenneth C. Lamp, & Lawrence V. Friedrich. (2007). Cubicin Outcomes Registry and Experience (CORE) Methodology. The American Journal of Medicine. 120(10). S4–S5. 42 indexed citations
15.
Lamp, Kenneth C., et al.. (2007). Clinical Experience with Daptomycin for the Treatment of Patients with Osteomyelitis. The American Journal of Medicine. 120(10). S13–S20. 80 indexed citations
16.
17.
Freeman, Collin D., Neil E. Klutman, & Kenneth C. Lamp. (1997). Metronidazole. Drugs. 54(5). 679–708. 379 indexed citations
18.
Lamp, Kenneth C., et al.. (1993). Prospective Evaluation of Red Man Syndrome in Patients Receiving Vancomycin. The Journal of Infectious Diseases. 168(3). 773–776. 33 indexed citations
19.
Lamp, Kenneth C., Elaine M. Bailey, & Michael J. Rybak. (1992). Ofloxacin Clinical Pharmacokinetics. Clinical Pharmacokinetics. 22(1). 32–46. 36 indexed citations
20.
Lamp, Kenneth C., et al.. (1991). Indomethacin for Prevention of Neonatal Intraventricular Hemorrhage. DICP. 25(12). 1344–1348. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barry Hafkin Breakdown of academic impact, for papers by Jon Bruss Breakdown of academic impact, for papers by Wendy Munckhof Breakdown of academic impact, for papers by A.P.R. Wilson Breakdown of academic impact, for papers by S. J. van Hal Breakdown of academic impact, for papers by Silvano Esposito Breakdown of academic impact, for papers by Donald H. Batts Breakdown of academic impact, for papers by Peter K. Linden Breakdown of academic impact, for papers by Kenneth J. Tack Breakdown of academic impact, for papers by James A. McKinnell
Rankless by CCL
2026